Observed situation in France for the week 51 of the year 2025, from 12/15/2025 to 12/21/2025 :
Published on 12-24-2025 15:12 - These news are updated on wednesday
Acute Respiratory Infection (ARI) Covid-19, Influenza and other respiratory viruses Définition
Moderate activity in general practice
Previously on sentiweb
In mainland France, last week (2025w51), the incidence rate of acute respiratory infection (ARI) cases consulting in general practice was estimated at 348 cases per 100,000 population (95% CI [336; 359]).
Subject to future data consolidation, this rate continues the increase observed in recent weeks and corresponds to a similar level of activity to those usually observed at this time of the year (consolidated data for 2025w50: 299 [289; 310]).
At the regional level, the highest incidence rates were noted in: Nouvelle-Aquitaine (596 [544; 648]), Bretagne (547 [487; 607]) and Provence-Alpes-Côte d’Azur (480 [429; 532]).
Influenza: the incidence rate of influenza cases seen in general practice for an ARI was estimated at 234 cases per 100,000 population (95% CI [205; 263]) (data sources: Sentinelles, SOS Médecins, Rouen, Côte d’Azur and Strasbourg Universities).
Subject to future data consolidation, this rate continues the sharp increase observed over the past three weeks (among children and adults) (consolidated data for 2025w50: 155 [137; 173]) and corresponds to a moderate level of activity.
RSV infection: the incidence rate of RSV infection cases seen in general practice for an ARI was estimated at 52 cases per 100,000 population (95% CI [38; 67]) (data sources: Sentinelles, SOS Médecins, Rouen, Côte d’Azur and Strasbourg Universities).
Subject to future data consolidation, this rate is increasing (among children and adults) (consolidated data for 2025w50: 34 [25; 43]) and corresponds to a high level of activity.
Bronchiolitis in children under one year old : the incidence rate of bronchiolitis cases in children under 1 seen in general practice was estimated at 404 cases per 100,000 population (95% CI [248; 560]) (data source: IQVIA (EMR)).
Subject to future data consolidation, this rate is stable (consolidated data for 2025w50: 476 [311; 641]) and corresponds to a lower activity level than those usually observed at this time of the year.
Covid-19: the incidence rate of Covid-19 cases seen in general practice for an ARI was estimated at 11 cases per 100,000 population (95% CI [8; 14]) (data source: Sentinelles).
Subject to future data consolidation, this rate is stable (consolidated data for 2025w50: 8 [6; 10]) and corresponds to a low level of activity.
| Estimated weekly incidence rate | Estimated weekly incidence | |
|---|---|---|
| France | 348 [336 ; 359] | 233061 [225398 ; 240724] |
| Regions | ||
| Grand Est | 348 [309 ; 387] | 19697 [17510 ; 21884] |
| Nouvelle-Aquitaine | 596 [544 ; 648] | 37254 [34015 ; 40493] |
| Auvergne-Rhône-Alpes | 306 [273 ; 339] | 25474 [22727 ; 28221] |
| Bourgogne-Franche-Comté | 247 [200 ; 293] | 7091 [5746 ; 8436] |
| Bretagne | 547 [487 ; 607] | 19189 [17079 ; 21299] |
| Centre-Val de Loire | 219 [174 ; 264] | 5774 [4579 ; 6969] |
| Corse | 384 [274 ; 495] | 1369 [975 ; 1763] |
| Ile-de-France | 273 [250 ; 297] | 34147 [31253 ; 37041] |
| Occitanie | 344 [301 ; 386] | 21312 [18671 ; 23953] |
| Hauts-de-France | 209 [179 ; 239] | 12733 [10907 ; 14559] |
| Normandie | 324 [275 ; 373] | 11042 [9365 ; 12719] |
| Pays de la Loire | 321 [267 ; 375] | 12752 [10604 ; 14900] |
| Provence-Alpes-Côte d'Azur | 480 [429 ; 532] | 25189 [22475 ; 27903] |
Table showing incidence and incidence rate for the geographic area of the information bloc and eventually for the geographic sub-levels
Acute diarrhea Définition
Low activity in general practice
Previously on sentiweb
In mainland France, last week (2025w51), the incidence rate of acute diarrhea cases seen in general practice was estimated at 72 cases per 100,000 population (95% CI [67; 77]).
Subject to future data consolidation, this rate is stable compared to the previous weeks and corresponds to a lower level of activity than those usually observed at this time of the year (consolidated data for 2025w50: 74 [69; 79]).
At the regional level, the highest incidence rates were noted in: Corse (105 [45; 164]), Grand Est (104 [83; 125]) and Nouvelle-Aquitaine (103 [81; 124]).
Data sources: Sentinelles and Electronic Medical Records (EMR) IQVIA
| Estimated weekly incidence rate | Estimated weekly incidence | |
|---|---|---|
| France | 72 [67 ; 77] | 48089 [44606 ; 51572] |
| Regions | ||
| Grand Est | 104 [83 ; 125] | 5888 [4678 ; 7098] |
| Nouvelle-Aquitaine | 103 [81 ; 124] | 6408 [5044 ; 7772] |
| Auvergne-Rhône-Alpes | 75 [59 ; 91] | 6239 [4903 ; 7575] |
| Bourgogne-Franche-Comté | 40 [20 ; 59] | 1141 [575 ; 1707] |
| Bretagne | 92 [66 ; 117] | 3218 [2327 ; 4109] |
| Centre-Val de Loire | 63 [37 ; 88] | 1651 [969 ; 2333] |
| Corse | 105 [45 ; 164] | 373 [161 ; 585] |
| Ile-de-France | 48 [38 ; 57] | 5960 [4780 ; 7140] |
| Occitanie | 83 [62 ; 104] | 5139 [3857 ; 6421] |
| Hauts-de-France | 65 [48 ; 82] | 3952 [2917 ; 4987] |
| Normandie | 31 [16 ; 46] | 1054 [549 ; 1559] |
| Pays de la Loire | 50 [29 ; 70] | 1974 [1166 ; 2782] |
| Provence-Alpes-Côte d'Azur | 95 [72 ; 118] | 4960 [3758 ; 6162] |
Table showing incidence and incidence rate for the geographic area of the information bloc and eventually for the geographic sub-levels
Subject to future data consolidation, this rate is stable compared to the previous week and corresponds to a similar level of activity to those usually observed at this time of the year (consolidated data for 2025w50: 13 [11; 15]).
At the regional level, the highest incidence rates were noted in: Corse (36 [0; 74]), Pays de la Loire (24 [10; 39]) and Centre-Val de Loire (19 [4; 34]).
Data sources: Sentinelles and Electronic Medical Records (EMR) IQVIA
| Estimated weekly incidence rate | Estimated weekly incidence | |
|---|---|---|
| France | 12 [10 ; 14] | 8000 [6568 ; 9432] |
| Regions | ||
| Grand Est | 6 [1 ; 12] | 361 [70 ; 652] |
| Nouvelle-Aquitaine | 11 [4 ; 19] | 715 [248 ; 1182] |
| Auvergne-Rhône-Alpes | 7 [2 ; 12] | 573 [182 ; 964] |
| Bourgogne-Franche-Comté | 12 [1 ; 24] | 359 [33 ; 685] |
| Bretagne | 12 [3 ; 20] | 410 [113 ; 707] |
| Centre-Val de Loire | 19 [4 ; 34] | 503 [105 ; 901] |
| Corse | 36 [0 ; 74] | 129 [0 ; 262] |
| Ile-de-France | 13 [8 ; 18] | 1590 [942 ; 2238] |
| Occitanie | 10 [4 ; 16] | 626 [244 ; 1008] |
| Hauts-de-France | 14 [7 ; 22] | 882 [397 ; 1367] |
| Normandie | 8 [1 ; 16] | 289 [22 ; 556] |
| Pays de la Loire | 24 [10 ; 39] | 959 [383 ; 1535] |
| Provence-Alpes-Côte d'Azur | 13 [4 ; 22] | 687 [218 ; 1156] |
Table showing incidence and incidence rate for the geographic area of the information bloc and eventually for the geographic sub-levels
Surveillance of acute respiratory infections by the Sentinelles network (Covid-19, influenza and RSV infections)
In March 2020, following the emergence of SARS-CoV-2 (COVID-19), the “Sentinelles surveillance” evolved. The surveillance of “influenza-like illness” (ILI, defined as sudden onset of fever above 39°C, accompanied by myalgia and respiratory signs) has been replaced by “acute respiratory infections” (ARI, defined as sudden onset of fever or feeling of fever and respiratory signs).
This new surveillance enables both the monitoring of the COVID-19 pandemic and epidemics due to other respiratory viruses (influenza, respiratory syncytial virus (RSV), rhinovirus and metapneumovirus). This surveillance is carried out with “Santé publique France” (the national agency for public health), the National Reference Center for respiratory infections (“Institut Pasteur” and “Hospices Civils de Lyon”) and the University of Corsica. This surveillance is based on patients consulting a general practitioner or a paediatrician for an ARI.
Data from the Sentinelles network are integrated into the overall national COVID-19 surveillance coordinated by “Santé publique France”. For more information, you can consult the weekly COVID-19 and influenza newsletters from “Santé publique France”.
At the same time, the Sentinelles network is carrying out studies and research on Covid-19, which are presented in the “Covid-19” section of this website.
